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Abstract
β-Secretase,BACE1isaneuron-speciﬁcmembrane-associatedproteasethatcleaves
amyloid precursor protein (APP) to generate β-amyloid protein (Aβ). BACE1 is
partially localized in lipid rafts. We investigated whether lipid raft localization of
BACE1 affects Aβ production in neurons using a palmitoylation-deﬁcient mutant
and further analyzed the relationship between palmitoylation of BACE1 and its
shedding and dimerization. We initially conﬁrmed that BACE1 is mainly palmi-
toylated at four C-terminal cysteine residues in stably transfected neuroblastoma
cells. We found that raft localization of mutant BACE1 lacking the palmitoyla-
tion modiﬁcation was markedly reduced in comparison to wild-type BACE1 in
neuroblastoma cells as well as rat primary cortical neurons expressing BACE1 via
recombinant adenoviruses. In primary neurons, expression of wild-type and mu-
tantBACE1enhancedproductionofAβ fromendogenousoroverexpressedAPPto
similarextentswiththeβ-C-terminalfragment(β-CTF)ofAPPmainlydistributed
in nonraft fractions. Similarly, β-CTF was recovered mainly in nonraft fractions
of neurons expressing Swedish mutant APP only. These results show that raft as-
sociation of BACE1 does not inﬂuence β-cleavage of APP and Aβ production in
neurons,andsupporttheviewthatBACE1cleavesAPPmainlyinnonraftdomains.
Thus, we propose a model of neuronal Aβ generation involving mobilization of
β-CTFfromnonrafttoraftdomains.Additionally,weobtaineddataindicatingthat
palmitoylation plays a role in BACE1 shedding but not dimerization.
Introduction
Cerebral accumulation of β-amyloid protein (Aβ)i sas p e -
ciﬁcneuropathologicalhallmarkofAlzheimer’sdisease(AD)
and is considered central to AD pathogenesis (Hardy and
Selkoe2002).Aβ isahydrophobicpeptidecomposedof∼40–
43 amino acids derived from proteolytic processing of amy-
loid precursor protein (APP). In amyloidogenic process-
ing, APP is initially cleaved by the β-secretase, BACE1,
and the resultant β-C-terminal fragment (β-CTF) subse-
quentlycleavedbyγ-secretasecomplexestogenerateAβ (De
Strooper2010).BACE1isamembrane-boundproteaseabun-
dantly expressed in neurons in the brain (Vassar et al. 1999)
that undergoes several posttranslational modiﬁcations in-
cluding glycosylation, phosphorylation, and palmitoylation
(Citron 2004; Stockley and O’Neill 2008). BACE1 deletion
abolishes Aβ production in mice without overt abnormali-
tiesandtheproteinisimplicatedinADpathogenesis,making
itanimportanttherapeutictargetforAD(Citron2004;Ohno
2008; Stockley and O’Neill 2008).
Lipid rafts are distinct membrane domains characterized
byhighconcentrationsofcholesterolandglycosphingolipids
(Laude and Prior 2004). Recent studies have identiﬁed lipid
rafts as important sites for the generation and accumula-
tion of Aβ (Cordy et al. 2006; Araki 2010; Rushworth and
Hooper 2010; Vetrivel and Thinakaran 2010). BACE1 and
270 c   2012 The Authors. Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative
Commons Attribution Non-Commercial License which permits use, distribution and reproduction in any medium, provided
the original work is properly cited and is not used for commercial purposes.K. Motoki et al. BACE1 in Lipid Rafts and Neuronal Aβ
γ-secretase complexes are partially and mainly localized in
lipid rafts, respectively (Riddle et al. 2001; Wahrle et al. 2002;
Cordy et al. 2003; Ehehalt et al. 2003; Vetrivel et al. 2004;
Urano et al. 2005; Hur et al. 2008). Previous reports in-
dicate that association of BACE1 with lipid rafts promotes
Aβ production, supporting the importance of this process
in Aβ generation. S-Palmitoylation of membrane proteins
plays important functional roles in protein–protein inter-
actions, folding, trafﬁcking, and association with lipid rafts
(Charollais and Van der Goot 2009). Vetrivel et al. (2009)
showed that BACE1 is S-palmitoylated at four C-terminal
cysteineresidues,anditslipidraftlocalizationisregulatedby
palmitoylation but has no direct impact on Aβ production
in murine cell lines. Owing to these controversial ﬁndings,
the issue of whether lipid raft association of BACE1 plays an
importantroleinAβ productioninneuronsremainsunclear
at present.
MatureBACE1ispartlycleavedintheextracellulardomain
to generate soluble BACE1 that is released extracellularly
(Benjannet et al. 2001; Hussain et al. 2003; Murayama et al.
2005).However,the physiologicalsigniﬁcanceofthisBACE1
shedding remains to be established. In addition, BACE1 ap-
pears to exist as a homodimer in the native state (Westmeyer
et al. 2004; Schmechel et al. 2004). We are yet to determine
whether BACE1 shedding and dimerization are affected by
its palmitoylation.
In this study, we sought to clarify whether lipid raft lo-
calization of BACE1 affects Aβ production in neurons. For
thispurpose,weemployedhumanneuroblastomacellsstably
expressing wild-type or mutant BACE1 lacking the palmi-
toylation modiﬁcation, as well as rat primary cortical neu-
ronsexpressingtheseformsofBACE1viarecombinantaden-
oviruses.OurﬁndingsprovideevidencethatBACE1cleavage
of APP and Aβ generation is independent of lipid raft asso-
ciation of the protease in neurons and suggest that BACE1
cleaves APP mainly in nonraft domains. Data from further
analyses indicate that palmitoylation plays a role in BACE1
shedding but not dimerization.
Materials and Methods
Antibodies
Four BACE1 antibodies were used: rabbit polyclonal anti-
body (NBA) raised against the N-terminal part of BACE1
(Murayama et al. 2005), mouse monoclonal anti-BACE1
ectodomain antibody (MAB9311, R&D Systems, Minneapo-
lis, MN), and rabbit polyclonal anti-BACE1 C-terminal
antibodies (M-83, Santa Cruz Biotechnology, Santa Cruz,
CA; AB5832, Millipore, Billerica, MA). Two rabbit poly-
clonal antibodies against the C-terminus of APP, designated
AC24 (Estus et al. 1992) and R37 (Kametani et al. 1993),
were employed. Mouse monoclonal 1D4 antibody to the
rhodopsin tag (VSKTETSQVAPA) (Hodges et al. 1988) was
Figure 1. Schematic illustration of BACE1 protein. BACE1 is palmitoy-
lated at four cysteine residues (Cys474, 478, 482, and 485) in the trans-
membrane (TM) and C-terminal cytoplasmic domains. BACE1 mutants
with three, four, and one Ala substitutions are designated as BACE1-
CA3, BACE1-CA4, and BACE1-C474A, respectively. The locations of the
epitopes for antibodies used in this study are also depicted.
obtained from University of British Columbia. Rabbit poly-
clonal antibodies against ﬂotillin-1 were purchased from
IBL (Gunma, Japan) and Sigma-Aldrich (St Louis, MO).
Mousemonoclonalanti-β-actinantibodywasacquiredfrom
Sigma. Horseradish peroxidase-conjugated secondary anti-
bodies against mouse or rabbit IgG were purchased from GE
Healthcare (Piscataway, NJ).
cDNA constructs
Human BACE1 cDNA fused with a C-terminal rhodopsin
tag was subcloned into the pcDNA3.1 vector (Invitrogen,
Carlsbad, CA). This plasmid was generously provided by Dr.
Michael Farzan (Farzan et al. 2000). Mutant BACE1 cDNAs
(BACE1-CA3, BACE1-CA4, and BACE1-C474A with three,
four, and one Cys-Ala substitutions, respectively) were gen-
erated (Fig. 1 ) using the GeneEditorTM in vitro mutagenesis
system (Promega, Madison, WI), according to the manufac-
turer’s instructions. The resultant cDNAs were veriﬁed by
sequencing.
Establishment of neuroblastoma cells stably
expressing BACE1
Human neuroblastoma SH-SY5Y cells were maintained in
a humidiﬁed atmosphere of 5% CO2/95% air in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) mixed at a 1:1 ratio with
Ham’s F-12 medium supplemented with 10% fetal bovine
serum. Wild-type or mutant BACE1 cDNA was transfected
into human neuroblastoma SH-SY5Y cells and stable trans-
formants selected with 400 μg/mL G418, as described previ-
ously (Takeda et al. 2004; Murayama et al. 2006).
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Primary neuronal cultures
Primaryneuronalcultureswerepreparedasdescribedearlier
(Brewer et al. 1993; Araki et al. 2001), with minor modiﬁ-
cations. Cerebral cortices were removed from rat embryos at
embryonic day 17, in Hank’s Balanced Salt Solution (with-
out Ca2+ and Mg2+) and the meninges discarded. Cortical
tissues were minced with surgical blades and dissociated via
trituration using ﬁre-polished Pasteur pipettes. Cells were
plated on a poly-l-lysine-coated 6-well plate or 6-cm dish in
Neurobasal medium containing B27 supplements (BD Bio-
sciences, San Jose, CA).
Generation of recombinant adenoviruses
Recombinant adenoviruses were prepared using an Aden-
ovirusDualExpressionVectorKit(TakaraBio,Shiga,Japan).
Brieﬂy, BACE1-WT, BACE1-CA4, and human wild-type and
Swedish mutant APP695 (Takeda et al. 2004) cDNA frag-
ments were blunted and inserted into the SwaI site of
the cosmid vector pAxCAwtit2 to generate pAxCAwtit2-
BACE1-WT, pAxCAwtit2-BACE1-CA4, pAxCAwtit2-APP,
and pAxCAwtit2-swAPP, respectively. After digesting with
BspT107I, recombinant cosmids were transfected into
HEK293 cells using Lipofectamine 2000 (Invitrogen). Re-
combinant adenoviruses were screened and propagated ac-
cording to the manufacturer’s instructions.
3H-Palmitic acid labeling
3H-palmitic acid (PA) labeling was performed essentially us-
ing a previously described method (Magee et al. 1995). In
brief,cellsplatedon6-cmdishwerelabeledwith0.2mCi3H-
PA for 5 h, and collected with a cell scraper. Cells were lysed
with RIPA (radioimmunoprecipitationassay) buffer, and ex-
tracts immunoprecipitated with 1D4 antibody and protein
G-agarose. Immunoprecipitates were treated with Laemmli
sample buffer, followed by SDS-PAGE. Gels were soaked in
DMSO for 30 min twice and 20% (w/w) diphenyloxazole in
DMSO for 3 h, and rinsed with water for 1 h. After drying,
gels were analyzed using ﬂuorography.
Immunoblot analysis
Immunoblot analyses were performed as described previ-
ously (Takeda et al. 2004; Murayama et al. 2006). Cells were
lysed in RIPA buffer (10 mM Tris-HCl, pH 8.0, 150 mM
NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.5% sodium de-
oxycholate, 0.1% SDS) containing protease inhibitors. Pro-
teins were separated on 8% polyacrylamide gels and blot-
ted onto polyvinylidene diﬂuoride membranes. Blots were
blocked in phosphate-buffered saline (PBS) containing
0.05% Tween-20 and 5% nonfat-dried milk, and probed
with the appropriate antibodies, followed by secondary
horseradishperoxidase-conjugatedanti-rabbitormouseIgG.
Signals were detected with enhanced chemiluminescence
reagents (Perkin-Elmer, Boston, MA), and the resulting im-
ages analyzed with a LAS-1000 (Fuji Film, Tokyo, Japan)
image analyzer.
Lipid raft isolation
Sucrose density gradient ultracentrifugation was performed
as described previously (Yoon et al. 2007; Oda et al.
2010). Brieﬂy, cell pellets were disrupted by 10 strokes
through a 25-G needle in TNE buffer (25 mM Tris,
pH 7.4, 150 mM NaCl, 2 mM EDTA) containing pro-
tease inhibitors. An equal volume of 2% CHAPS (3-[(3-
cholamidopropyl)dimethylammonio]propanesulfonate) in
TNE buffer was mixed and incubated on ice for 30 min.
Cell extracts were mixed with TNE buffer containing su-
crose to yield a ﬁnal concentration of 45% (w/v) sucrose,
and the mixture adds to the bottom of an ultracen-
trifuge tube. TNE buffers containing 35% and 5% su-
c r o s ew e r es u c c e s s i v e l ya n dc a r e f u l l yl a y e r e do v e rC H A P S
cell extracts. Samples were spun at 4◦C for 14–16 h
at 190,000 g in the SW60 rotor (Beckman, Fullerton,
CA). In total, 10 fractions were collected in 0.285 mL
volumes from the top to bottom. Equal volumes of each
fractionweresubjectedtoSDS-PAGEandimmunoblotting.
Aβ measurement
Primary neurons were cultured on a 6-well plate for 7 days
and infected with recombinant adenoviruses at a multi-
plicity of infection of ∼10. One day after infection, the
whole medium was changed, and the amounts of Aβ40 and
Aβ42 in 24 h-conditioned media measured using sandwich
ELISA kits (Wako, Osaka, Japan) (Suzuki et al. 1994; Araki
et al. 2001). Brieﬂy, samples and Aβ standard solutions were
applied to 96-well plates coated with BNT77 overnight at
4◦C, and incubated with horseradish peroxidase-conjugated
BA27 or BC05 for 2 h at room temperature. Bound en-
zyme activity was measured using the TMB microwell per-
oxidase substrate system (Kirkegaard & Perry Laboratories,
Gaithersburg, MD).
Immunocytochemistry
Primary neurons cultured on cover slips were ﬁxed with 4%
paraformaldehydeinPBS.Fixedcellswerepermeabilizedand
b l o c k e dwi t h0 . 3 %T ri t o nX - 1 0 0a n d1 %F B Si nP B S ,a n di n -
cubated with 1D4 antibody for 1 h, followed by DyLight649-
conjugated anti-mouse IgG (Jackson Immuno-Research
Laboratories, Bar Harbor, ME) for 1 h. For double immuno-
labeling, cells were subsequently stained with anti-ﬂotillin1
antibody (Sigma, St. Louis, MO, USA) and Alexa488-
conjugated anti-rabbit IgG (Invitrogen). Specimens were ex-
aminedwithaLeicaTCSSP2MPconfocalmicroscopesystem
(Leica Microsystems, Heidelberg, Germany).
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Immunoprecipitation
Soluble-BACE1
SH-SY5Y cells expressing BACE1 were cultured on 6-cm
dishes and grown overnight in serum-free DMEM/F12 con-
taining N2 supplements (BD Biosciences). Conditioned me-
dia were harvested, mixed with NP-40 (0.1%), Tris, pH 8
(10 mM), NaCl (150 mM), and protease inhibitors, and in-
cubated overnight at 4◦C with anti-BACE1 ectodomain an-
tibody (MAB9311) and protein G-agarose (Murayama et al.
2005). Immunoprecipitated materials were subjected to im-
munoblot analysis with BACE1 N-terminal (NBA) or C-
terminal (M-83) antibodies.
APP CTF
Fractions from lipid raft isolation experiments were diluted
10 times with TNE buffer and used for immunoprecipita-
tion with anti-APP antibodies (AC24). Immunoprecipitated
materials were subjected to Tris/Tricine SDS-PAGE and im-
munoblot analysis with anti-APP (R37).
Blue native polyacrylamide gel
electrophoresis
Blue native-PAGE (BN-PAGE) was performed as described
previously (Sch¨ agger and von Jagow 1991). Membrane and
cytosolic fractions of SH-SY5Y cells expressing BACE1 were
separated using a previously described method (Murayama
et al. 2006). The extracts were applied onto BN-PAGE
(4–16%), and transferred onto PVDF membranes. Blots
weredestainedfor1hindistilledwater/methanol/aceticacid
(60%/30%/10%)andsubjectedtoimmunoblottingwith1D4
antibodies.
Statistical analysis
All results are presented as means± SEM. Statistical analyses
were performed with Student’s t- t e s to ro n e - w a ya n a l y s i so f
variance (ANOVA), followed by Bonferroni multiple com-
parison test with a threshold of P < 0.05.
Results
BACE1 palmitoylation occurs mainly at four
cysteine residues in the C-terminal region
We investigated S-palmitoylation of BACE1 using human
neuroblastomacellsstablyexpressingBACE1.cDNAofwild-
type BACE1 (BACE1-WT) or mutant BACE1 (BACE1-CA3
or BACE1-CA4 with three or four Cys–Ala substitutions,
respectively) (Fig. 1) was transfected into SH-SY5Y cells and
stabletransfectants(designatedSH-BACE1-WT,SH-BACE1-
CA3, and SH-BACE1-CA4 cells) were established. Western
blotanalysisrevealedthatalltransfectedcellsexpressedequal
levels of BACE1 (Fig. 2a). Next, we evaluated palmitoylation
of BACE1 using 3H-PA labeling. As shown in Figure 2b, the
3H-PA-labeled BACE1 level was reduced to 23% and 2% in
BACE1-CA3-andBACE1-CA4-expressingcells,respectively,
compared to BACE1-WT cells. These ﬁndings indicate that
palmitoylation of BACE1 is abolished in the BACE1-CA4
mutant, conﬁrming that BACE1 is mainly modiﬁed at the
four cysteine residues in the C-terminal region.
Lipid raft distribution of BACE1 depends on
palmitoylation in neuroblastoma cells
Next, we evaluated the role of palmitoylation in lipid raft
distribution of BACE1 in SH-SY5Y cells via sucrose density
gradient centrifugation. Immunoblot analysis of individual
fractions showed that the raft marker, ﬂotillin-1, was present
infraction4,indicativeofthefractionationoflipidraftcom-
ponents. Although a proportion of BACE1 was recovered in
fraction 4, the majority of the protein was present in high-
density membrane fractions (fractions 7–10) (Fig. 3a). The
percentages of BACE1 distributed in the raft fraction per to-
tal BACE1 in all fractions for BACE1-WT, BACE1-CA3, and
BACE1-CA4 cells were 15.6%, 11.4%, and 5.8%, respectively
(Fig. 3a). These results indicate that lipid raft distribution of
BACE1 depends on its palmitoylation in SH-SY5Y cells.
Since the distribution patterns of BACE1 in SH-BACE1-
CA3 and SH-BACE1-CA4 cells were markedly different, we
examined the effect of palmitoylation at cysteine 474 alone.
Forthispurpose,weestablishedSH-SY5Ycellsstablyexpress-
ingBACE1-C474A(designatedSH-BACE1-C474Acells).No
signiﬁcant differences were observed in the percentage of
BACE1 within the raft fraction between SH-BACE1-WT and
SH-BACE1-C474Acells(Fig.3b),suggestingthatpalmitoyla-
tion speciﬁcally at cysteine 474 does not have a major impact
on lipid raft targeting of BACE1.
Lipid raft association of BACE1 depends on
palmitoylation in primary cortical neurons
We further evaluated lipid raft localization of BACE1 in rat
primary cortical neurons infected with recombinant aden-
oviruses expressing BACE1-WT or BACE1-CA4. Upon su-
crose density gradient fractionation, lipid rafts were recov-
eredmainlyinfraction4,whereﬂotillin-1waspredominantly
present. A proportion of BACE1 was recovered in fraction 4,
while the majority was present in high-density nonraft frac-
tions (fraction 8–10) (Fig. 4a). The percentage of BACE1
in the raft fraction was 14% and 3% in neurons expressing
BACE1-WT and BACE1-CA4, respectively (Fig. 4b), con-
ﬁrming that lipid raft association of BACE1 is dependent on
its palmitoylation in primary neurons as well.
Ap r o p o r t i o no fA P Pw a sd e t e c t e di nf r a c t i o n4 ,w i t ht h e
majority recovered from nonraft fractions. The percentages
of APP in the raft fraction were similar for SH-BACE1-WT-
and SH-BACE1-CA4-expressing cells (Fig. 4c), suggesting
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Figure 2. Four cysteine residues in BACE1 are palmitoylated. (a) Cell lysates of SH-BACAE1-WT, SH-BACE1-CA3, and SH-BACE1-CA4 cells were
analyzed by immunoblotting with 1D4 antibody. (b) Cells were labeled with
3H-palmitic acid, and lysates analyzed by immunoprecipitation with 1D4.
The relative levels of
3H-labeled BACE1 were calculated and graphed. Data are presented as means ± SEM from two independent experiments. *P <
0.01.
that raft distribution of BACE1 does not directly affect that
of APP.
We additionally evaluated the cellular localization of
BACE1 using double immunoﬂuorescence staining. Im-
munostaining with 1D4 revealed localization of BACE1 in
both soma and neurites. There were no appreciable dif-
ferences in the staining patterns between BACE1-WT- and
BACE1-CA4 (Fig. 4d). Upon double labeling with 1D4
and anti-ﬂotillin-1, ﬂotillin-1 immunoreactivity was ob-
served as punctate staining that partially overlapped that of
1D4. The extent of the colocalization of 1D4 and ﬂotillin-
1 immunoreactivities appeared reduced in neurons ex-
pressing BACE1-CA4, relative to those expressing BACE1-
WT (Fig. 4d), consistent with the results of biochemical
fractionation.
Aβ production is not inﬂuenced by raft
association of BACE1 in neurons
Since lipid rafts appear to represent an important site for
amyloidogenic processing of APP by BACE1 (Cordy et al.
2006; Araki 2010; Rushworth and Hooper 2010; Vetrivel and
Thinakaran2010),weanalyzedthesecretionofAβ frompri-
mary neurons overexpressing BACE1-WT or BACE1-CA4.
On Western blots, neurons expressed comparable levels of
BACE1-WT and BACE1-CA4 (Fig. 5a). BACE1-WT and
BACE1-CA4 enhanced secretion of both Aβ40 and Aβ42 to
similarextents(byapproximately80%),comparedtocontrol
cells infected with empty adenovirus (Fig. 5b and c).
To determine the effects of BACE1-WT and BACE1-CA4
on Aβ production from overexpressed APP, neurons were
infected with both recombinant wild-type APP and BACE1
adenoviruses. Compared to neurons expressing APP only,
mature APP levels were signiﬁcantly diminished in those
expressing APP plus BACE1-WT or APP plus BACE1-CA4,
suggesting that a signiﬁcant proportion of APP is cleaved
by BACE1 (Fig. 5d). Consistently, neurons coexpressing APP
and either BACE1-WT or BACE1-CA4 secreted ∼6.5-fold
higher amounts of Aβ40 and ∼2.5-fold or ∼2.9-fold higher
amounts of Aβ42, respectively, than those expressing APP
alone (Fig. 5e and f). Together, BACE1-WT and BACE1-
CA4 exerted similar Aβ-promoting effects, suggesting that
β-cleavage of APP does not depend on raft localization of
BACE1.
β-CTF is predominantly localized in nonraft
membrane domains
To evaluate the β-cleavage of APP in raft and nonraft do-
mains, we performed Western blot analysis of APP CTF.
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Figure 3. Lipid raft distribution of BACE1 depends on palmitoylation in
neuroblastomacells.(a)SH-BACE1-WT,SH-BACE1-CA3,andSH-BACE1-
CA4 cells were subjected to sucrose density gradient fractionation, as
described in section Materials and Methods. Each fraction was analyzed
by Western blotting with 1D4 or anti-ﬂotillin-1 (a marker protein for lipid
rafts). The BACE1 level in each fraction was quantiﬁed and expressed
as a percentage per total BACE1 level in whole fractions. (b) Similar
analysis performed using SH-BACE1-WT and SH-BA-C474A cells. Data
are presented as means ± SEM from three independent experiments.
*P < 0.01, compared with SH-BACE1-WT cells;
#P < 0.05, compared
with SH-BACE1-CA3 cells.
Western blots of RIPA lysates revealed that levels of β-CTF
andβ -CTF(derivedfromalternativeBACE1cleavageofAPP
betweenTyr10andGlu11withintheAβregion)wereremark-
ablyincreased and those of α-CTF (derived from α-secretase
cleavage of APP between Lys16 and Leu17 within the Aβ re-
gion) decreased in neurons expressing APP plus BACE1-WT
orAPPplusBACE1-CA4,comparedtothoseexpressingAPP
alone(Fig.6a).Subsequently,weexaminedthedistributionof
APPCTFinraftandnonraftfractionsfollowingsucroseden-
sity gradient fractionation. Immunoprecipitation–Western
blotanalysisrevealedthatthemajorityofβ-CTFandβ -CTF
was recovered in nonraft fractions (fractions 8–10) of neu-
rons expressing APP plus BACE1-WT or APP plus BACE1-
CA4,whereasonlylowlevelswerepresentintheraftfraction
(fraction4).NodifferencesinthelocalizationpatternofCTFs
were observed between neurons expressing BACE1-WT and
BACE1-CA4 (Fig. 6b).
Next, we evaluated the β-cleavage of APP by endogenous
BACE1. For this purpose, primary neurons overexpressing
Swedish mutant APP, a preferred substrate of BACE1, via
recombinant adenoviruses were treated with a γ-secretase
inhibitor DAPT (N-[N-(3,5-diﬂuorophenacetyl)-l-alanyl]-
(S)-phenylglycine t-butyl ester) (Dovey et al. 2001) that
augments the levels of APP CTF. The distributions of en-
dogenous BACE1 and APP CTF were then analyzed follow-
ing sucrose density gradient fractionation. Bands of BACE1
were observed in both raft and nonraft fractions and faint
bands probably representing dimeric BACE1 were addition-
ally detected in nonraft fractions (Fig. 6c). Higher levels
of β-CTF and β -CTF were obviously recovered in non-
raft fractions than in the raft fraction (Fig. 6d). These
results suggest that β-cleavage of APP by overexpressed
as well as endogenous BACE1 occurs mainly in nonraft
fractions.
Shedding of BACE1 is regulated by
palmitoylation
Next, we focused on the effects of palmitoylation on BACE1
shedding. As reported previously (Murayama et al. 2005),
immunoprecipitation–Western blot analysis of conditioned
media of SH-BACE1-WT cells revealed two bands corre-
sponding to soluble BACE1 (sol-BACE1) and full-length
BACE1 (FL-BACE1) (Fig. 7a). Compared to SH-BACE1-
WT cells, the FL-BACE1 level appeared increased, while
that of sol-BACE1 was decreased in media of SH-BACE-
CA4 cells (Fig. 7a). Quantitative analysis disclosed a signif-
icant increase in the FL-BACE1/sol-BACE1 ratio in the me-
dia of SH-BACE1-CA4 cells relative to SH-BACE1-WT cells
(Fig. 7b).
BACE1 shedding was additionally analyzed in primary
neurons expressing BACE1-WT or BACE1-CA4. The FL-
BACE1/sol-BACE1ratiointheconditionedmediawassignif-
icantly increased in BACE1-CA4-expressing neurons, com-
pared to BACE1-WT-expressing neurons (Fig. 7c and d). Al-
together,theresultssuggestthatBACE1sheddingispositively
regulated by palmitoylation.
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Figure 4. Lipid raft distribution of BACE1 depends on palmitoylation in primary rat cerebral cortical neurons. (a) CHAPS extracts of cultured neurons
infected with recombinant adenoviruses expressing BACE1-WT or BACE1-CA4 were fractionated via sucrose density gradient fractionation, and
analyzed by Western blotting with 1D4, anti-APP (R37), or anti-ﬂotillin-1 antibodies. (b, c) The relative levels of individual fractions were quantiﬁed
as for Fig. 3 and graphed. Data are presented as means ± SEM from three independent experiments. *P < 0.01. (d) Neurons grown on cover slips
were infected with recombinant adenoviruses as above, ﬁxed, and analyzed via double immunoﬂuorescence staining with 1D4 (red) and anti-ﬂotillin-1
(green). Nuclei were visualized with DAPI (4’, 6’-diamidino-2-phenylindole) staining (blue). Scale bar, 10 μm.
BACE1 dimerization is not affected by
palmitoylation
Finally, we investigated whether palmitoylation affects the
homodimer formation of BACE1. Extracts of the mem-
branefractionsofSH-BACE1-WT,SH-BACE1-CA3,andSH-
BACE1-CA4 cells were separated using BN-PAGE, followed
by Western blotting. For SH-BACE1-WT cells, a band with
mass of ∼160 kDa instead of the expected mass of ∼70 kDa
reacted with the 1D4 antibody, conﬁrming that BACE1 ex-
ists as a homodimer under native conditions (Fig. 8a and
b). Similarly, only the band representing dimeric BACE1
was observed in SH-BACE1-CA3 and SH-BACE1-CA4 cells
(Fig. 8b). Therefore, BACE1 dimer formationappeared to be
unaffected by palmitoylation.
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Figure 5. Neuronal Aβ production is not inﬂuenced by raft association of BACE1. (a–c) Cultured neurons were infected with recombinant adenoviruses
expressing BACE1-WT, BACE1-CA4, or empty adenoviruses (mock). (a) Cell lysates were analyzed by Western blotting using NBA antibody for BACE1
or R37 antibody for APP. The amounts of Aβ40 (b) and Aβ42 (c) in conditioned media were determined with sandwich ELISA as described in section
Materials and Methods. (d–f) Neurons were infected with recombinant APP adenoviruses plus empty adenoviruses or recombinant adenoviruses
expressing BACE1-WT or BACE1-CA4. Western blotting (d) and Aβ measurement (e, f) were performed as above. BACE1-WT or BACE1-CA4 had
comparable effects on the production of Aβ40 and Aβ42. Values represent means ± SEM from three separate experiments. *P < 0.05, **P < 0.01.
Discussion
The issue of whether lipid raft association of BACE1 plays
a signiﬁcant role in neuronal Aβ production remains con-
troversial. We therefore sought to clarify this issue, as its
resolution would shed light on the mechanisms underly-
ing BACE1 regulation and assist in the development of ef-
fective disease-modifying therapeutics for AD. Using neu-
roblastoma cells expressing wild-type BACE1 (BACE1-WT)
or mutant BACE1 (BACE1-CA3, BACE1-CA4, and BACE1-
C474A), we conﬁrmed that BACE1 is palmitoylated at four
Cys residues in the juxtamembrane and C-terminal regions,
in accordance with data from a recent study by Vetrivel et al.
(2009).RaftlocalizationofBACE1-CA4withoutpalmitoyla-
tion sites was markedly reduced in both neuroblastoma cells
and primary cerebral cortical neurons, indicating that raft
targeting of BACE1 is palmitoylation dependent. Our sub-
sequent analysis revealed that BACE1-WT and BACE1-CA4
promoted neuronal production of Aβ40 and Aβ42 from en-
dogenous and overexpressed APP to similar extents. These
results clearly indicate that BACE1 raft localization does not
affect Aβ production in neurons, in agreement with a previ-
ous report (Vetrivel et al. 2009) in which BACE1-null ﬁbrob-
lasts and mouse N2a neuroblastoma cells were used for ex-
periments. Furthermore, we observed that both β-CTF and
β -CTF metabolites derived from BACE1 processing were
mainly localized in the nonraft fractions of neurons express-
ing APP and either BACE1-WT or BACE1-CA4. We addi-
tionally observed that β-CTF derived from APP cleavage by
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Figure 6. Predominant localization of APP CTF
in nonraft domains of neurons coexpressing
APP and BACE1. (a) RIPA or CHAPS extracts of
neurons coexpressing APP and either mock or
BACE1-WT or BACE1-CA4 were subjected to
Tris/Tricine SDS-PAGE and immunoblotting with
anti-APP. We observed remarkable increases in
the levels of β-CTF and β
 -CTF in both neurons
expressing BACE1-WT and BACE1-CA4.
(b) CHAPS extracts in (a) were fractionated using
sucrose density gradient centrifugation, and raft
(4) and nonraft (8-10) fractions analyzed by
immunoprecipitation–Western blot analysis with
anti-APP, as described in section Materials and
Methods. The majority of β-CTF and β
 -CTF was
recovered in nonraft fractions of both neurons
expressing BACE1-WT and BACE1-CA4. Each
diagram is representative of two independent
experiments with essentially identical results.
(c) Neurons expressing Swedish mutant APP
were treated with 0.5 μM DAPT for 1 day, and
subjected to sucrose density gradient
fractionation, as in (b). Each fraction was
analyzed by Western blot analysis with anti-APP,
anti-BACE1 (AB5832), and anti-ﬂotillin-1.
(d) CHAPS extracts (Ex) and raft (4) and nonraft
(7-10) fractions in (c) were analyzed by
immunoprecipitation–Western blot analysis with
anti-APP, as above. β-CTF and β
 -CTF were
mainly recovered in nonraft fractions. Each
diagram is representative of three experiments
with essentially identical results.
endogenous BACE1 also distributes mainly in nonraft frac-
tions of neurons expressing Swedish mutant APP. These data
support the view that BACE1 cleavage of APP occurs mainly
in the nonraft domains in neurons.
A mutant form of BACE1 (BACE1-GPI) in which trans-
membraneandcytoplasmicdomainsarereplacedwithglyco-
sylphosphatidylinositol (GPI) anchor attachment signal that
preferentially localizes in lipid rafts was reported to exhibit
increased β-cleavage activity (Cordy et al. 2003). However,
a recent study has revealed that the increase in Aβ secre-
tionundertheconditionofBACE1-GPIexpressionismainly
due to reduced APP cleavage at the β -site, compared with
wild-type BACE1 (Vetrivel et al. 2011). It is likely that β-
site cleavage efﬁciency of BACE1 is essentially unaltered by
its association with lipid rafts. Based on the present and
earlier results, we propose a dynamic model of neuronal
Aβ generation,asillustratedinFig.9.First,APPiscleavedby
BACE1 mainly in nonraft domains, generating β-CTF. Next,
β-CTF mobilizes from nonraft to raft domains through un-
knownmechanisms,whereitisﬁnallycleavedbyγ-secretase,
resulting in Aβ production. Thus, identiﬁcation of the spe-
ciﬁc factors involved in the transport of β-CTF from nonraft
to raft domains is an important subject of focus for future
research.
Endosomes and the trans-Golgi network are important
organelles for the production of Aβ and β-CTF. A previous
study (Vetrivel et al. 2009) presented evidence that palmitoy-
lationofBACE1doesnotregulateitsdistributionintheseor-
ganellesoratthecellsurface.Thus,BACE1-WTandBACE1-
CA4 likely exert β-cleavage activity in nonraft domains of
the same subcellular sites. Interestingly, the β -CTF level was
higher than that of β-CTF in neurons coexpressing APP and
BACE1. Consistently, a recent study has indicated that β -
cleavage is a major processing event that occurs with human
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Figure 7. BACE1 shedding is regulated by
palmitoylation. (a) Conditioned media of
SH-BACE1-WT or SH-BACE1-CA4 cells were
analyzed by immunoprecipitation–Western blot
analysis, as described in section Materials and
Methods. Two bands corresponding to FL-BACE1
and sol-BACE1 were detected with the NBA
antibody, while only the upper FL-BACE1 band was
recognized with the M83 antibody. (b) Band
intensities of FL-BACE1 and sol-BACE1 (a) were
quantitated and the FL-BACE1/sol-BACE1 ratios
calculated. (c, d) Conditioned media of neurons
infected with recombinant adenoviruses expressing
BACE1-WT or BACE1-CA4 were analyzed as for (a)
FL-BACE1/sol-BACE1 ratios were calculated and
graphed as for (b). Data are presented as means ±
SEM from three independent experiments.
*P < 0.05.
Figure 8. BACE1 dimerization is not affected by palmitoylation. Ex-
tracts of membrane fractions of SH-BACE1-WT, SH-BACE1-CA3, or
SH-BACE1-CA4 cells were separated using SDS-PAGE (a) or BN-PAGE
(b), and analyzed via Western blotting with 1D4. On BN-PAGE, only a
∼160-kDa band most likely corresponding to dimeric BACE1 was ob-
served in all three cell types. Each diagram is representative of two
independent experiments that gave essentially identical results.
APPinneuronalcultures(Zhouetal.2011).Itispossiblethat
β -CTF is generated via cleavage of β-CTF by BACE1, since
Vetrivel et al. (2011) showed that BACE1 readily processes
β-CTF into β -CTF in COS cells.
In BACE1-expressing cell medium, soluble as well as full-
lengthBACE1aredetected.Weshowedpreviouslythattreat-
mentwithametalloproteaseinhibitorTAPI-1reducesBACE1
shedding but increases full-length BACE1 release, suggesting
that these two events are interrelated physiological processes
(Murayama et al. 2005). In the present study, we showed that
the FL-BACE1/sol-BACE1 ratio was signiﬁcantly increased
in the media of SH-SY5Y cells and primary neurons express-
ing BACE1-CA4, compared to those expressing BACE1-WT.
These results suggest that BACE1 shedding is reduced in the
absence of BACE1 palmitoylation, although the underlying
mechanism is yet to be established. It is unlikely that lack
of raft localization of BACE1 is related to reduced shedding
because metalloproteases responsible for BACE1 shedding,
such as ADAM10, are predominantly distributed in nonraft
fractions (Kojro et al. 2001). Palmitoylation of BACE1 may
affect the physical interactions between BACE1 and its shed-
dases and promote BACE1 shedding.
BACE1 exists as a homodimer under native conditions.
DimerformationcouldbeinﬂuencedbyBACE1posttransla-
tionalmodiﬁcationssuchaspalmitoylation.Previousstudies
have indicated that dimerization of BACE1 is inhibited in
bHEK cells treated with cerulenin, which has an inhibitory
effect on palmitoylation (Parsons and Austen 2005), imply-
ing a role of palmitoylation in BACE1 dimerization. How-
ever, BN-PAGE analysis disclosed no differences in dimer
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Figure9. HypotheticalmodelforAPPprocessing.APPprocessinginneu-
rons is possibly a dynamic process involving three steps. (I) APP is cleaved
by BACE1 mainly in nonraft domains, generating β-CTF. (II) β-CTF is
transported from nonraft to raft domains via unknown mechanisms. (III)
β-CTF is cleaved by γ-secretase in raft domains, generating Aβ and AICD
(APP intracellular domain).
formation between BACE1-WT and BACE1-CA4 proteins.
Thus, it appears that palmitoylation of BACE1 does not di-
rectly inﬂuence dimerization.
It is likely that BACE1 in lipid rafts has functional roles
otherthanprocessingofAPP.BACE1cleavesanumberofsub-
strates,includingneuregulins,p-selectinglycoproteinligand-
1, β-subunits of voltage-gated sodium channels, and lipo-
protein receptor-related protein (Lichtenthaler et al. 2003;
von Arnim et al. 2005; Wong et al. 2005; Hu et al. 2006;
Willemetal.2006;Kimetal.2007).ItisplausiblethatBACE1
functions to cleave these membrane proteins that are local-
ized in lipid rafts. In our immunocytochemical analysis of
BACE1-expressing neurons, BACE1 immunoreactivity was
observed throughout neuronal processes, implying activity
in the metabolism of speciﬁc synaptic proteins.
The mechanisms underlying regulation of BACE1 activ-
ity in neurons are complex (Stockley and O’Neill 2008). We
and others have demonstrated that reticulon (RTN) proteins
such as RTN3 and RTN4-B/C interact with BACE1 and in-
hibit its β-cleavage activity (He et al. 2004; Murayama et al.
2006). Our preliminary data indicate that RTN3 and RTN4-
B/Cmostlydistributedinnonraftdomains(datanotshown)
where they appear to regulate BACE1. It is important to
make further investigations of nonraft membrane domains
as a possible site of physiological regulation of BACE1. The
hypothetical model of APP processing involves mobilization
of β-CTF. However, the transport mechanism of β-CTF be-
tween nonraft and raft domains remains to be elucidated;
resolving this issue would provide a basis for the identiﬁca-
tion of new therapeutic targets for AD.
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